塔尔苏斯制药 TARS
$68.60 +$1.08 (+1.60%)
休市 · Nov 8, 5:10 am ET · 最新盘后价 $70.00 +2.04%
开盘$67.78
昨收$67.52
当日区间$66.53 – $69.04
成交量1.09M
市值$3.38B
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数9
平均目标价$100.13+46.0% 较现价
- 买入 100%
最低 $84.00现价 $68.60均值 $100.13最高 $116.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$84.00至$116.00，平均为$99.83。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 29 Oct 2026 | Mizuho Securities | BUY | $94.00 |
| 12 Oct 2026 | BofA Securities | BUY | $84.00 |
| 9 Oct 2026 | Barclays | BUY | $110.00 |
| 2 Oct 2026 | Oppenheimer | BUY | $100.00 |
| 24 Sep 2026 | Goldman Sachs | BUY | $116.00 |
| 16 Sep 2026 | Barclays | BUY | $110.00 |
| 8 Sep 2026 | Jefferies | BUY | $105.00 |
| 12 Aug 2026 | William Blair | BUY | – |
| 12 Aug 2026 | Oppenheimer | BUY | $100.00 |
| 11 Aug 2026 | Mizuho Securities | BUY | $100.00 |
| 8 Aug 2026 | LifeSci Capital | BUY | $104.00 |
| 7 Aug 2026 | LifeSci Capital | BUY | $104.00 |
| 7 Aug 2026 | Mizuho Securities | BUY | $100.00 |
| 7 Aug 2026 | H.C. Wainwright | BUY | $88.00 |
| 4 Aug 2026 | Mizuho Securities | BUY | $98.00 |
| 31 Jul 2026 | Mizuho Securities | BUY | $98.00 |
| 21 Jul 2026 | Guggenheim | BUY | $89.00 |
| 21 Jul 2026 | Oppenheimer | BUY | $97.00 |
| 14 Jul 2026 | William Blair | BUY | – |
| 14 Jul 2026 | Mizuho Securities | BUY | $100.00 |
暂无评论——快来第一个聊聊 TARS。
登录后参与讨论。